Keyt Bruce 4
4 · IGM Biosciences, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-03-14$10.17/sh−1,844$18,754→ 171,856 total - Sale
Common Stock
2024-03-13$9.88/sh−2,101$20,748→ 173,700 total
Holdings
- 4,039(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $9.625 to $10.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $9.80 to $10.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]The securities are held directly by the reporting person's spouse.